Systematic review / meta-analysis / 2012
Soy isoflavone supplements significantly reduced menopausal hot flash frequency and severity.
A systematic review and meta-analysis analyzed randomized controlled trials evaluating soy isoflavones given for 6 weeks to 12 months (median dose 54 mg aglycone equivalents daily). Isoflavone intake reduced hot flash frequency by 20.6% (95% CI -28.38 to -12.86; 13 trials) and severity by 26.2% (95% CI -42.23 to -10.15; 9 trials) compared with placebo. Products providing over 18.8 mg genistein demonstrated greater efficacy.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- Perimenopausal and postmenopausal women across 19 randomized trials
- What was measured
- hot flash frequency and severity
THE PAPER
Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. Menopause, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.